{"schema_version":"secwatch.filing_event.v1","accession":"0001380106-22-000007","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2022-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.218350+00:00","generated_at":"2026-06-27T01:29:17.287844+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Rapid Micro Biosystems FY2021 commercial revenue up 54% to $21.6M; net loss $73.5M","bullets":["FY2021 total revenue $23.2M vs $16.1M; commercial revenue $21.6M (+54%); net loss $73.5M vs $37.1M.","Q4 2021 total revenue $5.2M flat YoY; commercial revenue $4.9M; recurring revenue $2.3M (+91%).","FY2022 commercial revenue guidance reaffirmed at $27M-$32M (25-50% growth).","Cash, cash equivalents and investments $203.5M, no debt.","Placed 29 new systems FY2021; cumulative placed 116, validated 84."],"urls":{"canonical":"https://secwatch.observer/filing/0001380106-22-000007","json":"https://secwatch.observer/filing/0001380106-22-000007.json","markdown":"https://secwatch.observer/filing/0001380106-22-000007.md","text":"https://secwatch.observer/filing/0001380106-22-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000138010622000007/0001380106-22-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000138010622000007/c106-20220304x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:29:17.287844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}